UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.208

Sortiert nach

Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group

Annals of oncology, 2010-01, Vol.21 (1), p.114-119

2010

Volltextzugriff (PDF)

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification

Leukemia, 2024-02, Vol.38 (2), p.442-445

2024

Volltextzugriff (PDF)

Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study

Leukemia, 2012-06, Vol.26 (6), p.1286-1292

2012

Volltextzugriff (PDF)

Features of the Processing of Cellulose-Containing Raw Materials with Aspergillus Niger Enzyme Systems to Obtain Bioethanol

IOP conference series. Earth and environmental science, 2021-09, Vol.852 (1), p.12056

2021

Volltextzugriff (PDF)

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

Leukemia, 2011-01, Vol.25 (1), p.110-120

2011

Volltextzugriff (PDF)

Monosomal karyotype in MDS: explaining the poor prognosis?

Leukemia, 2013-10, Vol.27 (10), p.1988-1995

2013

Volltextzugriff (PDF)

Features of processing the biomass of genus Miscanthus plants into carbohydrate-containing substrates for biotechnology

IOP conference series. Earth and environmental science, 2021-03, Vol.699 (1), p.12056

2021

Volltextzugriff (PDF)

Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes

Annals of oncology, 2010-01, Vol.21 (1), p.120-125

2010

Volltextzugriff (PDF)

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)

Leukemia, 2005-12, Vol.19 (12), p.2223-2231

2005

Volltextzugriff (PDF)

Histological Analysis of Endocrine Disruptive Effects in Small Laboratory Fish

1, 2009

Volltextzugriff (PDF)

Mietrecht und Wohnungsmangelgesetzgebung: Im Reiche, in Preußen und in Berlin, einschl. Hauszinssteuer, Kostenwesen und Rechtsentscheiden des Kammergerichts

Krieg, O

2021

Volltextzugriff (PDF)

Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis

Annals of hematology, 2014, Vol.93 (1), p.57-64

2014

Volltextzugriff (PDF)

Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform

European journal of clinical investigation, 2008-03, Vol.38 (3), p.143-149

2008

Volltextzugriff (PDF)

Biological Effective Dose (BED) in Evaluation of Rectal Dose in Prostate Cancer Patients with Hydrogel Spacer Who Underwent an EBRT with Different Fractionation Schemes

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e744-e744

2023

Volltextzugriff (PDF)

What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small country

Bone marrow transplantation (Basingstoke), 2012-02, Vol.47 (2), p.172-180

2012

Volltextzugriff (PDF)

Erratum to: Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multicenter trial by the Austrian Working Group For Medical Tumor Therapy

Annals of hematology, 2014-03, Vol.93 (3), p.539-540

2014

Volltextzugriff (PDF)

P-111 Time changes in predictive power of MDS prognostic scores – Effects on revised scores such as the IPSS-R, impact of age

Leukemia research, 2013-05, Vol.37, p.S73-S73

2013

Volltextzugriff (PDF)

Allogeneic Stem Cell Transplantation In Patients With Acute Myeloid Leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)

Clinical lymphoma, myeloma and leukemia, 2015-06, Vol.15, p.S183-S183

2015

Volltextzugriff (PDF)

O-023 Did the prognosis of MDS patients improve during the last 30 years?

Leukemia research, 2013-05, Vol.37, p.S19-S19

2013

Volltextzugriff (PDF)

318 A novel score optimized for accurate prediction of survival in patients with de novo myelodysplastic syndromes

Leukemia research, 2011, Vol.35, p.S127-S127

2011

Volltextzugriff (PDF)

P-113 Revised International Prognostic Scoring System (IPSS-R) for primary treated myelodysplastic syndromes (MDS) patients: A report from the IWG-PM

Leukemia research, 2013-05, Vol.37, p.S74-S75

2013

Volltextzugriff (PDF)

154 Some determinants of disease specific mortality in MDS

Leukemia research, 2011-05, Vol.35, p.S60-S61

2011

Volltextzugriff (PDF)

Konkursordnung und Anfechtungsgesetz: Mit Anmerkungen unter besonderer Berücksichtigung der Entscheidungen des Reichsgerichts

2021

Volltextzugriff (PDF)

1 – 25 von 1.208

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(925)
Mit Volltextzugriff
(1.061)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification

Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study

Features of the Processing of Cellulose-Containing Raw Materials with Aspergillus Niger Enzyme Systems to Obtain Bioethanol

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

Monosomal karyotype in MDS: explaining the poor prognosis?

Features of processing the biomass of genus Miscanthus plants into carbohydrate-containing substrates for biotechnology

Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)

Histological Analysis of Endocrine Disruptive Effects in Small Laboratory Fish

Mietrecht und Wohnungsmangelgesetzgebung: Im Reiche, in Preußen und in Berlin, einschl. Hauszinssteuer, Kostenwesen und Rechtsentscheiden des Kammergerichts

Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis

Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform

Biological Effective Dose (BED) in Evaluation of Rectal Dose in Prostate Cancer Patients with Hydrogel Spacer Who Underwent an EBRT with Different Fractionation Schemes

What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small country

Erratum to: Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multicenter trial by the Austrian Working Group For Medical Tumor Therapy

P-111 Time changes in predictive power of MDS prognostic scores – Effects on revised scores such as the IPSS-R, impact of age

Allogeneic Stem Cell Transplantation In Patients With Acute Myeloid Leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)

O-023 Did the prognosis of MDS patients improve during the last 30 years?

318 A novel score optimized for accurate prediction of survival in patients with de novo myelodysplastic syndromes

P-113 Revised International Prognostic Scoring System (IPSS-R) for primary treated myelodysplastic syndromes (MDS) patients: A report from the IWG-PM

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

154 Some determinants of disease specific mortality in MDS

Konkursordnung und Anfechtungsgesetz: Mit Anmerkungen unter besonderer Berücksichtigung der Entscheidungen des Reichsgerichts

Suchergebnisse filtern